8/16/2013 10:01:01 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ATLANTA--(BUSINESS WIRE)--The Alzheimer’s Drug Discover Foundation (ADDF) and the Foundation for Mitochondrial Medicine (FMM) announce a partnership to drive innovative translational research for mitochondrial dysfunction. ADDF and FMM will provide grants up to $200,000 for a one-year duration with possibile follow-on funding. Mitochondria dysfunction underlies many different diseases. The brain is particularly vulnerable to changes in energy use that occur with age or because of underlying disease pathology. Novel therapies that can correct defects in mitochondria functioning have the potential to impact many different diseases – from early childhood genetic diseases to late-life neurodegenerative diseases such as Alzheimer’s disease.
Help employers find you! Check out all the jobs and post your resume.
comments powered by